| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
An antigenic chimaera of poliovirus type 1 expressing an epitope from human papillomavirus type 16
|
Jenkins, O.
|
|
1989
|
7 |
2 |
p. 184-
1 p.
|
article
|
| 2 |
A nationwide vaccination programme in Italy against hepatitis B virus infection in infants of hepatitis B surface antigen-carrier mothers
|
Stroffolini, Tommaso
|
|
1989
|
7 |
2 |
p. 152-154
3 p.
|
article
|
| 3 |
Anti-fertility vaccines
|
Talwar, G.P.
|
|
1989
|
7 |
2 |
p. 97-101
5 p.
|
article
|
| 4 |
Attenuated cytomegalovirus capable of cellular infection containing a foreign gene capable of expression in a cytomegalovirus-infected host cell; potential vaccine
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 5 |
Attenuated vaccinia virus recombinant containing a lymphokine, especially interleukin-2, gene and optionally foreign antigen genes; useful for making vaccine
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 6 |
A vaccine to genital papillomaviruses: is it feasible?
|
McCance, D.J.
|
|
1989
|
7 |
2 |
p. 183-
1 p.
|
article
|
| 7 |
Calendar
|
|
|
1989
|
7 |
2 |
p. 192-
1 p.
|
article
|
| 8 |
Candidate vaccines for HIV
|
Girard, Marc
|
|
1989
|
7 |
2 |
p. 188-189
2 p.
|
article
|
| 9 |
Cattle leukaemia vaccine containing recombinant vaccinia virus incorporating cattle leukaemia virus surface antigen gene
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 10 |
Cell- and serum-mediated protection against Chlamydia psittaci infection of the mouse
|
Buzoni-Gatel, D.
|
|
1989
|
7 |
2 |
p. 178-179
2 p.
|
article
|
| 11 |
Cellular and molecular approaches to the development of a vaccine for syphilis: current status and prospects for the future
|
Miller, James N.
|
|
1989
|
7 |
2 |
p. 180-
1 p.
|
article
|
| 12 |
Characterization of an HSV-1 subunit vaccine and its enhanced immunogenicity in the form of an immunostimulating complex preparation
|
Erturk, M.A.
|
|
1989
|
7 |
2 |
p. 186-
1 p.
|
article
|
| 13 |
Cloned DNA to lassavirus nucleoprotein and glycoprotein gene used for the generation of live recombinant viruses for vaccines and diagnostic reagents
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 14 |
Comparative study of the safety and protective value, in pre-exposure use, of rabies vaccine cultivated on human diploid cells (HDCV) and of the new vaccine grown on Vero cells
|
Ajjan, N.
|
|
1989
|
7 |
2 |
p. 125-128
4 p.
|
article
|
| 15 |
Conference information
|
|
|
1989
|
7 |
2 |
p. 170-
1 p.
|
article
|
| 16 |
Conference programme
|
|
|
1989
|
7 |
2 |
p. 172-173
2 p.
|
article
|
| 17 |
Current and future hepatitis B vaccines
|
Zuckerman, Arie J.
|
|
1989
|
7 |
2 |
p. 181-
1 p.
|
article
|
| 18 |
D.651, a vaccine for the prevention of recurrent vulvovaginal candidiasis
|
Levy, D.A.
|
|
1989
|
7 |
2 |
p. 176-
1 p.
|
article
|
| 19 |
Development and Clinical studies with a recombinant DNA hepatitis B vaccine
|
Andre, F.E.
|
|
1989
|
7 |
2 |
p. 181-182
2 p.
|
article
|
| 20 |
Development of a vaccine for gonorrhoea
|
Mulloy, W.P.
|
|
1989
|
7 |
2 |
p. 176-177
2 p.
|
article
|
| 21 |
DNA encoding hepatitis B virus antigens and hybrids containing them — expression in yeast for malaria and hepatitis B vaccine preparation
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 22 |
Dog-distemper virus vaccine preparation from virus inactivated by exposure to binary ethyleneimine or ultraviolet irradiation in the presence of furocoumarin compound
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 23 |
Duration of immunity to hepatitis B vaccination in institutionalized mentally retarded patients
|
Torre, Donato
|
|
1989
|
7 |
2 |
p. 102-103
2 p.
|
article
|
| 24 |
Editorial
|
|
|
1989
|
7 |
2 |
p. 91-
1 p.
|
article
|
| 25 |
Effect of formalin treatment on antigenicity of herpes simplex virus type 1 glycoprotein D
|
Ridgeway, P.H.
|
|
1989
|
7 |
2 |
p. 187-
1 p.
|
article
|
| 26 |
Effect of timing of hepatitis B vaccine doses on response to vaccine in Yucpa Indians
|
Hadler, Stephen C.
|
|
1989
|
7 |
2 |
p. 106-110
5 p.
|
article
|
| 27 |
Efficacy of purified herpes virus glycoprotein vaccines in animal models
|
Mishkin, E.
|
|
1989
|
7 |
2 |
p. 185-
1 p.
|
article
|
| 28 |
Efficacy of yeast-derived glycoprotein B of herpes simplex virus (HSV) on the development of herpetic lesion after intravaginal challenge with HSV type 2
|
Kino, Yoichiro
|
|
1989
|
7 |
2 |
p. 185-
1 p.
|
article
|
| 29 |
Epidemiology and control of sexually transmitted diseases: the global picture
|
Meheus, André
|
|
1989
|
7 |
2 |
p. 174-
1 p.
|
article
|
| 30 |
Evaluation in animal models of genetically engineered herpes simplex virus R7020, a prototype HSV vaccine
|
Meignier, Bernard
|
|
1989
|
7 |
2 |
p. 186-
1 p.
|
article
|
| 31 |
Experimental syphilis vaccines: aro-Salmonella typhimurium expressing recombinant Treponema pallidum antigens
|
Strugnell, R.
|
|
1989
|
7 |
2 |
p. 180-
1 p.
|
article
|
| 32 |
Expression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein
|
Phalipon, A.
|
|
1989
|
7 |
2 |
p. 132-136
5 p.
|
article
|
| 33 |
Expression of human papillomavirus genes in cervical tissue and their roles in malignant transformation
|
Schoolnik, Gary K.
|
|
1989
|
7 |
2 |
p. 183-
1 p.
|
article
|
| 34 |
Expression of precore-core or preS1-preS2-S genes of hepatitis B virus in vertebrate, e.g. mouse NIH3T3, cell culture
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 35 |
Factors affecting the transmission rates of genital herpes: considerations for designing vaccine field trials
|
Corey, L.
|
|
1989
|
7 |
2 |
p. 186-
1 p.
|
article
|
| 36 |
Fluorometric assay for the measurement of viral neuraminidase in influenza vaccines
|
Lambré, Claude R.
|
|
1989
|
7 |
2 |
p. 104-105
2 p.
|
article
|
| 37 |
Formation and characterization of FeLV ISCOMs
|
Åkerblom, L.
|
|
1989
|
7 |
2 |
p. 142-146
5 p.
|
article
|
| 38 |
Genes encoding Mycobacterium tuberculosis protein antigens useful for tuberculosis vaccine preparation and therapy
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 39 |
Glycosylated and non-glycosylated proteins of HSV-1: relevance to vaccine development
|
Skinner, G.R.B.
|
|
1989
|
7 |
2 |
p. 187-
1 p.
|
article
|
| 40 |
Herpes simplex vaccines, current status and future prospects
|
Meignier, Bernard
|
|
1989
|
7 |
2 |
p. 184-
1 p.
|
article
|
| 41 |
HIV antigens and their variability
|
Weiss, R.A.
|
|
1989
|
7 |
2 |
p. 188-
1 p.
|
article
|
| 42 |
HIV-1 epitope expression on a chimaeric poliovirus vaccine vector
|
Evans, David
|
|
1989
|
7 |
2 |
p. 189-190
2 p.
|
article
|
| 43 |
HIV virus envelope polypeptides, variants and antibodies used in immune disease, e.g. AIDS, diagnosis, therapy and vaccine production
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 44 |
ICRC ‘anti-leprosy vaccine’
|
Deo, M.G.
|
|
1989
|
7 |
2 |
p. 92-93
2 p.
|
article
|
| 45 |
Identification of IgA immunogenic proteins in chlamydial and herpes simplex virus type II infections by Western blotting
|
Lehtinen, M.
|
|
1989
|
7 |
2 |
p. 179-
1 p.
|
article
|
| 46 |
Immune responses to a 104-mer synthetic peptide of the major internal protein, gag (p24) of the human immunodeficiency virus (HIV-1)
|
Sia, D.Y.
|
|
1989
|
7 |
2 |
p. 190-
1 p.
|
article
|
| 47 |
Immune response to immunostimulatory complexes prepared from human immunodeficiency virus and the external envelope glycoprotein
|
Pyle, S.W.
|
|
1989
|
7 |
2 |
p. 190-
1 p.
|
article
|
| 48 |
Immunity to chlamydial infections and the outlook for vaccination
|
Taylor-Robinson, D.
|
|
1989
|
7 |
2 |
p. 177-
1 p.
|
article
|
| 49 |
Immunogenicity of herpes simplex virus glycoprotein gB-1-related protein produced in yeast
|
Kino, Yoichiro
|
|
1989
|
7 |
2 |
p. 155-160
6 p.
|
article
|
| 50 |
Immunogenicity of peptide fusions to hepatitis B core antigen
|
Stahl, Stephen
|
|
1989
|
7 |
2 |
p. 182-
1 p.
|
article
|
| 51 |
Immunological principles of vaccine design
|
Virelizier, Jean-Louis
|
|
1989
|
7 |
2 |
p. 174-
1 p.
|
article
|
| 52 |
Immunology of HIV
|
Essex, M.
|
|
1989
|
7 |
2 |
p. 188-
1 p.
|
article
|
| 53 |
International testing of vaccine candidates for HIV: scientific, ethical and legal aspects
|
Esparza, J.
|
|
1989
|
7 |
2 |
p. 181-
1 p.
|
article
|
| 54 |
Intranasal immunization with proteoliposomes protects against influenza
|
El Guink, Nadia
|
|
1989
|
7 |
2 |
p. 147-151
5 p.
|
article
|
| 55 |
ISCOM technology and the presentation of synthetic peptides
|
Howard, C.R.
|
|
1989
|
7 |
2 |
p. 182-
1 p.
|
article
|
| 56 |
Large-scale production, purification and immunological analysis of vaccinia recombinant derived HIV-1 gp160
|
Barrett, N.
|
|
1989
|
7 |
2 |
p. 189-
1 p.
|
article
|
| 57 |
Lymphocyte proliferative responses to chlamydial antigens in patients with ocular chlamydial infections
|
Mabey, D.C.W.
|
|
1989
|
7 |
2 |
p. 179-
1 p.
|
article
|
| 58 |
Molecular biology of gonococcal porin protein P.I, a candidate vaccine component
|
Carbonetti, Nicholas
|
|
1989
|
7 |
2 |
p. 175-
1 p.
|
article
|
| 59 |
Neutralizing epitopes on the major outer membrane protein of Chlamydia trachomatis
|
Conlan, J.W.
|
|
1989
|
7 |
2 |
p. 178-
1 p.
|
article
|
| 60 |
New cholera vaccines
|
Holmgren, Jan
|
|
1989
|
7 |
2 |
p. 94-96
3 p.
|
article
|
| 61 |
New immunosuppressive peptides useful as FLV, HIV and HTLV vaccines and for producing antibodies for detecting leukaemia and other cancers
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 62 |
New plasmid containing genes for nontoxic forms of Escherichia coli enterotoxin and transformed cells useful in vaccines against diarrhoea, especially in pigs
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 63 |
New retrovirus related to HIV virus-1 from T-lymphocyte cell culture derived from paraparesis patients after activation
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 64 |
Novel reactors for vaccines
|
Clyde, Robert
|
|
1989
|
7 |
2 |
p. 191-
1 p.
|
article
|
| 65 |
Oral cholera vaccines containing B-subunit-killed whole cells and killed whole cells only. I. Cross-reacting antigens of members of family Vibrionaceae and the vaccines
|
Čižnǎr, I.
|
|
1989
|
7 |
2 |
p. 111-116
6 p.
|
article
|
| 66 |
Oral cholera vaccines containing B-subunit—killed whole cells and killed whole cells only. II. Field evaluation of cross-protection against other members of the Vibrionaceae family
|
Clemens, John D.
|
|
1989
|
7 |
2 |
p. 117-120
4 p.
|
article
|
| 67 |
Oral Immunization Symposium
|
Edelman, Robert
|
|
1989
|
7 |
2 |
p. 166-167
2 p.
|
article
|
| 68 |
Polypeptides reactive with anti-human lymphocyte T4 for use in HIV virus, e.g. AIDS, vaccine production; monoclonal antibody production and hybridoma construction
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 69 |
Poor immunogenicity as the reason for the ineffectiveness of a glycoprotein subunit vaccine for genital herpes
|
Ashley, R.
|
|
1989
|
7 |
2 |
p. 184-185
2 p.
|
article
|
| 70 |
Potential of immunosomes, liposomes and virosomes in infections with HIV
|
Hildebrand, Goran D.
|
|
1989
|
7 |
2 |
p. 191-
1 p.
|
article
|
| 71 |
Potential of the anti-idiotype approach for the development of an anti-HIV vaccine
|
Dalgleish, A.G.
|
|
1989
|
7 |
2 |
p. 189-
1 p.
|
article
|
| 72 |
Preliminary studies towards the development of a subunit cytomegalovirus vaccine
|
Billstrom, M.
|
|
1989
|
7 |
2 |
p. 190-191
2 p.
|
article
|
| 73 |
Preparation and characterization of pilus synthetic peptide-major iron-regulating protein conjugate vaccine for the prevention of gonococcal infections
|
Dupuy, M.
|
|
1989
|
7 |
2 |
p. 176-
1 p.
|
article
|
| 74 |
Preparation of a subunit vaccine against herpes simplex
|
Talei, G.R.
|
|
1989
|
7 |
2 |
p. 187-
1 p.
|
article
|
| 75 |
Preparation of immune complex herpes simplex vaccine using human sera
|
Shariff, D.
|
|
1989
|
7 |
2 |
p. 187-
1 p.
|
article
|
| 76 |
Presentation of Chlamydia trachomatis epitopes on a poliovirus vaccine vector
|
Burke, K.L.
|
|
1989
|
7 |
2 |
p. 177-
1 p.
|
article
|
| 77 |
Prevention of Chlamydia infections by oral immunization: an effective immunoprophylatic approach for pulmonary and genital infection
|
LaScolea Jr., Leonard J.
|
|
1989
|
7 |
2 |
p. 178-
1 p.
|
article
|
| 78 |
Problems and prospects for the development of a vaccine against gonorrhoea
|
Heckels, John E.
|
|
1989
|
7 |
2 |
p. 175-
1 p.
|
article
|
| 79 |
Production of a hepatitis B virus surface antigen polypeptide and vaccine protein sequence
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 80 |
Production of recombinant Chlamydia trachomatis serovar D major outer membrane protein
|
Maclean, I.
|
|
1989
|
7 |
2 |
p. 179-180
2 p.
|
article
|
| 81 |
Protection against genital herpes simplex virus (HSV) infection and disease with a recombinant gD glycoprotein vaccine
|
Burke, R.L.
|
|
1989
|
7 |
2 |
p. 184-
1 p.
|
article
|
| 82 |
Protective capacity of a ribosomal vaccine against Candida albicans
|
Dussourd d'Hinterland, L.
|
|
1989
|
7 |
2 |
p. 177-
1 p.
|
article
|
| 83 |
Putative failures of recombinant DNA hepatitis B vaccines
|
Arya, S.C.
|
|
1989
|
7 |
2 |
p. 164-165
2 p.
|
article
|
| 84 |
Recombinant avipox virus and expression vector plasmid pNZ180, etc., useful in Marek disease, infectious laryngotracheobronchitis, infectious coryza and coccidioidosis recombinant vaccine production
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 85 |
Recombinant bluetongue virus protein production in insect cells, e.g. Spodoptera frugiperda; application in vaccine manufacture
|
|
|
1989
|
7 |
2 |
p. 161-
1 p.
|
article
|
| 86 |
Recombinant hepatitis B surface antigen (Re-HBs)
|
Bumelis, V.
|
|
1989
|
7 |
2 |
p. 183-
1 p.
|
article
|
| 87 |
Regression of bovine lymphosarcoma by treatment with cell-wall skeleton of Nocardia rubra
|
Onuma, Misao
|
|
1989
|
7 |
2 |
p. 121-124
4 p.
|
article
|
| 88 |
Report on follow-up of consorts at risk immunized with Skinner vaccine
|
Skinner, G.R.B.
|
|
1989
|
7 |
2 |
p. 185-
1 p.
|
article
|
| 89 |
Selection and suitability of adjuvants
|
Stewart-Tull, D.E.S.
|
|
1989
|
7 |
2 |
p. 174-
1 p.
|
article
|
| 90 |
Serological responses in cats vaccinated with FeLV ISCOM and an inactivated FeLV vaccine
|
Osterhaus, A.
|
|
1989
|
7 |
2 |
p. 137-141
5 p.
|
article
|
| 91 |
Seroprevalence of lymphogranuloma venereum agents in northern Nigeria: a preliminary study
|
Eghafona, N.O.
|
|
1989
|
7 |
2 |
p. 179-
1 p.
|
article
|
| 92 |
Serum and vaginal fluid antibodies against the gonococcal major iron-regulated protein in women with pelvic inflammatory disease or uncomplicated infection
|
Morse, S.A.
|
|
1989
|
7 |
2 |
p. 175-
1 p.
|
article
|
| 93 |
Sexually-transmitted disease vaccine requirements: a US perspective
|
Alexander, E.R.
|
|
1989
|
7 |
2 |
p. 181-
1 p.
|
article
|
| 94 |
Specificity of serum immunoglobulin G subclass response to gonorrhoea in women
|
Ison, C.A.
|
|
1989
|
7 |
2 |
p. 176-
1 p.
|
article
|
| 95 |
Stability and safety of a chlamydial live vaccine against enzootic abortion of ewes
|
Rodolakis, Annie
|
|
1989
|
7 |
2 |
p. 178-
1 p.
|
article
|
| 96 |
Stability of an antifertility vaccine consisting of gonadotropin subunits linked to tetanus toxoid
|
Alam, Anis
|
|
1989
|
7 |
2 |
p. 129-131
3 p.
|
article
|
| 97 |
Studies on vaccination against HIV and FIV
|
Jarrett, W.
|
|
1989
|
7 |
2 |
p. 188-
1 p.
|
article
|
| 98 |
Sustained release immunity from adjuvanted vaccines
|
Brancq, B.
|
|
1989
|
7 |
2 |
p. 182-
1 p.
|
article
|
| 99 |
Synthetic anti-caries peptide vaccine preparation active against Streptococcus mutans; monoclonal antibody preparation and hybridoma construction
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 100 |
Synthetic peptide corresponding to HIV virus glycoprotein 160 envelope sequence which activates T-lymphocytes against HIV proliferation and may be used in an AIDS vaccine
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 101 |
Towards an AIDS vaccine - recombinant Ty: HIV virus-like particles
|
Adams, S.
|
|
1989
|
7 |
2 |
p. 189-
1 p.
|
article
|
| 102 |
Vaccination against papovavirus-induced tumours using vaccinia recombinants expressing non-structural proteins
|
Lathe, R.
|
|
1989
|
7 |
2 |
p. 183-
1 p.
|
article
|
| 103 |
Vaccine for immunization against a parasitic worm Dirofilaria immitis or A. conium comprising genetically engineered mutants Caenorhabditis elegans and Caenorhabditis briggsae
|
|
|
1989
|
7 |
2 |
p. 162-
1 p.
|
article
|
| 104 |
Vector containing yeast arg3 regulatory region used for production of hepatitis B virus surface antigen for use in vaccine
|
|
|
1989
|
7 |
2 |
p. 163-
1 p.
|
article
|
| 105 |
Viral Hepatitis and Liver Disease
|
Hilleman, Maurice R.
|
|
1989
|
7 |
2 |
p. 165-
1 p.
|
article
|
| 106 |
Zwitterionic-detergent-extracted subunit HSV-1 vaccine preparations and their effect on HSV-1 latency in mice
|
Al-Ghamdi, A.
|
|
1989
|
7 |
2 |
p. 186-
1 p.
|
article
|
Journal description